Healthcare Services

Cardiac AI Monitoring And Diagnostics Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Cardiac AI Monitoring And Diagnostics Market During 2026–2030?

The cardiac ai monitoring and diagnostics market size has experienced significant expansion in recent years. It is projected to climb from $2.14 billion in 2025 to $2.71 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 26.3%. Historically, this growth can be attributed to the rising incidence of cardiovascular diseases, enhanced availability of digital cardiac monitoring devices, the increasing adoption of ECG diagnostics in hospitals, the expansion of clinical cardiology services, and advancements in medical data analytics.

The cardiac AI monitoring and diagnostics market is projected to experience rapid expansion in the coming years. Its value is anticipated to reach $6.94 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 26.5%. This growth during the forecast period can be primarily attributed to several factors, including the increasing integration of AI-powered diagnostic instruments, a heightened need for remote patient surveillance solutions, the broadening scope of customized cardiac treatment, the expanding fusion of AI with medical imaging and biomarkers, and a greater emphasis on identifying diseases at early stages. Key developments expected over this period encompass a wider embrace of AI-based ECG analysis, the expanding implementation of remote cardiac observation platforms, an increasing application of predictive analytics within cardiology, the proliferation of wearable AI-enabled heart devices, and an improved unification of diverse cardiac data streams.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13820&type=smp

What Drivers Are Expected To Influence The Cardiac AI Monitoring And Diagnostics Market During The Forecast Period?

The rising incidence of cardiovascular diseases is anticipated to drive the expansion of cardiac AI monitoring and diagnostics. Cardiovascular diseases (CVDs) encompass various conditions affecting the heart and blood vessels, such as cerebrovascular disease, coronary heart disease, and rheumatic heart disease. Cardiac AI monitoring and diagnostics play a crucial role in the early detection, risk evaluation, and personalized treatment of these conditions, leading to improved patient outcomes. A relevant example illustrates this: in August 2025, the National Institutes of Health, a US-based government agency, projected that from 2025 to 2050, cardiovascular prevalence would increase by 90%, mortality by 73%, and DALYs by 55%, with deaths climbing from 20.5 million to 35.6 million. Consequently, the increasing occurrence of cardiovascular diseases is fueling the cardiac AI monitoring and diagnostics market.

How Are The Various Segments Of The Cardiac AI Monitoring And Diagnostics Market Categorized?

The cardiac ai monitoring and diagnostics market covered in this report is segmented –

1) By Function: Cardiac Diagnostics, Cardiac Monitoring

2) By Product: Software, Hardware

3) By Application: Ischemic Heart Diseases Or Coronary Artery Disease (CAD), Cardiac Arrhythmias

4) By End Users: Hospitals, Diagnostic Centers, Other End Users

Subsegments:

1) By Cardiac Diagnostics: ECG Analysis, Echocardiography Analysis, Cardiac Imaging

2) By Cardiac Monitoring: Wearable Cardiac Monitors, Remote Patient Monitoring Systems, Implantable Cardiac Devices, Continuous ECG Monitoring Systems

Which Trends Are Influencing The Cardiac AI Monitoring And Diagnostics Market?

Leading companies in the cardiac AI monitoring and diagnostics market are concentrating on developing technology-driven medical devices, such as artificial intelligence-based implantable cardiac monitors, to enhance their standing. Artificial intelligence-based implantable cardiac monitors are tools designed for the continuous tracking of cardiac function. For example, in May 2023, Biotronik, a German cardiovascular biomedical research and technology company, announced that the US Food and Drug Administration (FDA) had approved its BIOMONITOR IV implantable cardiac monitor (ICM). The BIOMONITOR IV implantable cardiac monitor (ICM) utilizes BIOTRONIK’s innovative, AI-powered SmartECG algorithm, which includes advanced processing that eliminates 86% of all false identifications while retaining 98% of genuine episodes. This groundbreaking technology boosts detection accuracy for healthcare professionals, minimizing false positive alerts and helping them achieve swift and precise diagnoses of specific cardiac issues. In addition to SmartECG technology, BIOMONITOR IV is the first ICM to differentiate between premature ventricular contractions (PVCs) and premature atrial contractions (PACs).

Which Major Firms Influence Developments In The Cardiac AI Monitoring And Diagnostics Market?

Major companies operating in the cardiac ai monitoring and diagnostics market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, ZOLL Medical Corporation, Canon Medical Systems Corporation, Biotronik SE & Co. KG, iRhythm Technologies Inc., Tempus Labs Inc., Viz.ai Inc., HeartFlow Inc., Aidoc, Eko Devices Inc., CardioFocus Inc., Circle Cardiovascular Imaging Inc., Ultromics Limited., Cathworks, Medicalgorithmics S.A., Nanox.AI Ltd, Cardiac Insight Inc., CardioSecur GmbH, Cardionomic Inc., HeartSciences, CardioComm Solutions Inc., CardioDiagnostics Inc.

Read the full cardiac ai monitoring and diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/cardiac-ai-monitoring-and-diagnostics-global-market-report

Which Region Is Forecast To Lead The Cardiac AI Monitoring And Diagnostics Market In Terms Of Market Size?

North America was the largest region in the cardiac AI monitoring and diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac ai monitoring and diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cardiac AI Monitoring And Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13820&type=smp

Browse Through More Reports Similar to the Global Cardiac AI Monitoring And Diagnostics Market 2026, By The Business Research Company

Carcinoembryonic Antigen Global Market Report

https://www.thebusinessresearchcompany.com/report/carcinoembryonic-antigen-global-market-report

Basal Cell Carcinoma Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/basal-cell-carcinoma-treatment-global-market-report

Desmoid Tumors Global Market Report

https://www.thebusinessresearchcompany.com/report/desmoid-tumors-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795